Co-Diagnostics (CODX) director receives 1,695-share equity grant

Rhea-AI Filing Summary

Co-Diagnostics, Inc. director Edward L. Murphy reported equity compensation activity. He received a grant of 1,695 shares of common stock at $0.00 per share, classified as a grant or award. On the same date, he exercised 1,695 restricted stock units into common stock. Following these transactions, he directly holds 11,084 shares of common stock and 4,000 restricted stock units, reflecting both current ownership and remaining stock-based incentives.

Insider Trade Summary

1,695 shares exercised/converted

Mixed 2 txns

Insider Murphy Edward L.

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	1,695	$0.00	--
Grant/Award	Common Stock	1,695	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 4,000 shares (Direct, null); Common Stock — 11,084 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Common shares granted: 1,695 shares RSUs exercised: 1,695 units Shares held after transactions: 11,084 shares +3 more

6 metrics

Common shares granted 1,695 shares Grant or award of common stock on May 23, 2026

RSUs exercised 1,695 units Restricted stock units converted into common stock on May 23, 2026

Shares held after transactions 11,084 shares Direct common stock ownership following Form 4 transactions

RSUs held after transactions 4,000 units Direct restricted stock unit holdings following the exercise

Acquisition transactions count 2 transactions Both reported transactions classified as acquisitions

Derivative exercises 1,695 shares ExerciseShares in transactionSummary for RSU conversion

Key Terms

Restricted Stock Unit, derivative security, Grant, award, or other acquisition, Long Term Incentive Plan, +1 more

5 terms

Restricted Stock Unit financial

"security_title: "Restricted Stock Unit""

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Long Term Incentive Plan financial

"pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan"

A long term incentive plan is a company program that awards executives and key employees bonuses—often in stock, options, or cash—only if the business meets multi-year performance goals. It links management pay to company results—like tying a coach’s bonus to a team’s multi-season record—so investors monitor it for how leaders are motivated, potential share dilution, and signals about the company’s long-term priorities.

restricted stock units financial

"Included in 2,334 restricted stock units awarded to the Reporting Person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Murphy Edward L.

(Last) (First) (Middle)

2401 S. FOOTHILL DRIVE SUITE D

(Street)

SALT LAKE CITY UTAH 84109

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Co-Diagnostics, Inc. [ CODX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/23/2026		A		1,695(1)	A	$0.00	11,084	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.00	05/23/2026		M			1,695	(1)	(1)	Common Stock	5,695	$0.00	4,000	D

Explanation of Responses:

1. Included in 2,334 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023. Included in 3,667 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2024. Included in 4,167 restricted stock units awarded to the Reporting Person on August 13, 2025, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2025.

Remarks:

	/s/ Edward L. Murphy	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did CODX director Edward L. Murphy report?

Edward L. Murphy reported receiving 1,695 shares of Co-Diagnostics common stock as a grant and exercising 1,695 restricted stock units into common shares. These are compensation-related acquisitions rather than open-market purchases or sales.

How many Co-Diagnostics (CODX) shares does Edward L. Murphy own after this filing?

After these transactions, Edward L. Murphy directly holds 11,084 shares of Co-Diagnostics common stock. This figure reflects his post-transaction position as reported in the Form 4, excluding any additional derivative awards not shown as common stock.

What happened to Edward L. Murphy’s restricted stock units in this CODX Form 4?

Murphy exercised 1,695 restricted stock units into common stock and now holds 4,000 restricted stock units directly. These RSUs are part of his stock-based compensation and may convert into common shares as they vest over time under plan terms.

Were Edward L. Murphy’s CODX transactions open-market buys or sells?

The reported transactions were not open-market trades. They were a grant or award of 1,695 common shares and an exercise of 1,695 restricted stock units, both classified as acquisitions related to compensation rather than discretionary market purchases or sales.

What incentive plan is mentioned in Edward L. Murphy’s CODX Form 4 footnote?

The footnote references the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan. It explains that Murphy’s restricted stock units were awarded under this plan and vest in equal installments every six months starting on specified November 23 dates for different award years.